Filing Details

Accession Number:
0001214659-22-003623
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-04 06:06:43
Reporting Period:
2022-03-02
Accepted Time:
2022-03-04 06:06:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1293310 Humanigen Inc HGEN Pharmaceutical Preparations (2834) 770557236
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1421882 Cameron Durrant C/O Humanigen, Inc. 830 Morris Turnpike
4Th Floor
Short Hills NJ 07078
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-02 40,000 $2.34 70,000 No 4 P Indirect By Cameron Durrant Revocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Cameron Durrant Revocable Trust
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.295 to $2.34, inclusive. The reporting person undertakes to provide upon request to the issuer, the Securities and Exchange Commission or any security holder of the issuer full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.